Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion type Assertion NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_head.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion description "[GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_provenance.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion evidence source_evidence_literature NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_provenance.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion SIO_000772 18084281 NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_provenance.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion wasDerivedFrom befree-20150227 NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_provenance.
- NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_assertion wasGeneratedBy ECO_0000203 NP832429.RA6vZjKz8f2eLfMA7EMxVTVFuSyP9E6F9VeapB9EFY4Wc130_provenance.